Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Analysis of Factors Related to Occurrence of Serious Adverse Events During Nursing in Intensive Care Units (NURSIE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03475238
Recruitment Status : Completed
First Posted : March 23, 2018
Last Update Posted : February 15, 2019
Sponsor:
Information provided by (Responsible Party):
French Society for Intensive Care

Brief Summary:

Patients who are hospitalized in intensive care unit (ICU) require basic nursing care to improve patient hygiene, to promote comfort, to prevent pressure ulcer, and foot or hand's retractations.

Those nursing cares require mobilization very frequently which expose critically ill patients to occurrence of serious adverse events (SAE) such as i) hemodynamic, neurologic, and respiratory variations ii) unplanned dislodgement (lines, drains, catheters, endotracheal tube..)

Few study have evaluated relation between SAE occurence and several patient's, service's, health-care provider's caracteristics. We plan to analyse those factors to find some ways to prevent SAE occurence during nursing and hygiene cares.


Condition or disease Intervention/treatment
Nursing Caries Critical Care Procedure: Nursing care

Layout table for study information
Study Type : Observational
Actual Enrollment : 262 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Nursing Research on the Occurrence of Serious Adverse Events in Intensive Care Unit During Bed Bath and Nursing Care. NURSIE Study
Actual Study Start Date : March 29, 2018
Actual Primary Completion Date : July 15, 2018
Actual Study Completion Date : February 13, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Critical Care

Group/Cohort Intervention/treatment
Cohort for nursing care
Patients in ICU under oxygen and/or mechanical ventilation and/or vasoactive drugs and/or non-invasive ventilation
Procedure: Nursing care
The nursing care will be defined as a lateral mobibization and a length of care superior or equal to 10 min




Primary Outcome Measures :
  1. Incidence of occurrence of at least one serious avderse event (SAE) (defined below) during the nursing care while the study period (72 hours) [ Time Frame: 72 hours ]

    Determinate incidence of occurrence of at least one SAE (defined below) during the nursing care while the study period (72 hours) The nursing care will be defined as a lateral mobibization and a length of care sup or equal to 10min

    SAE are considered according to litterature as :

    • Cardiac arest
    • Unplanned extubation
    • Episode of Spo2 riequiring therapeutic intervention
    • Artificial airway obstruction requiring endotracheal suctionning
    • Unplanned dislodgements related to lines or catheters drains
    • Hypotension with therapeutic intervention
    • Cardiac rhythm disorders with therapeutic intervention
    • Agitation with therapeutic intervention
    • Equipment failure or dysfunction
    • Patient fall
    • Need for doctor help
    • Increased intracranial pressure > 20 mmHg
    • Acute painful crisis



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Each participating unit will include all consecutive patients staying in the ICU.

Each day a screening of the patients will be released between 8 and 10 am.

Criteria

Inclusion Criteria:

  • Health-care affiliated
  • Length of ICU stay < 72 h
  • Patient with endotracheal tube
  • Patient with tracheostomy
  • Patient receiving vasoactives drugs (norepinephrine, epinephrine, Dobutamine)
  • Patient undergoing no invasive ventilation during 1hour minimum of 24 hours before the selection
  • Patient undergoing hight flow oxygen therapy heated and humidified

Exclusion Criteria:

  • Patient already included in this study
  • Medical contraindication to the bed bath with lateral mobilization
  • Withdrawal of life sustaining treatment
  • Spinal trauma

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03475238


Locations
Show Show 26 study locations
Sponsors and Collaborators
French Society for Intensive Care
Investigators
Layout table for investigator information
Study Director: Mathieu Lloung French Intensive Care Society
Study Chair: Jean Baptiste Lascarrou, MD French Intensive Care Society
Layout table for additonal information
Responsible Party: French Society for Intensive Care
ClinicalTrials.gov Identifier: NCT03475238    
Other Study ID Numbers: 2018-A00046-49
First Posted: March 23, 2018    Key Record Dates
Last Update Posted: February 15, 2019
Last Verified: February 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by French Society for Intensive Care:
critical care